GlassScriptPhysician profile
Lukasz Maj
NPI 1770779282
$16,731.64
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,922 · 2020: $7,090 · 2021: $319 · 2022: $166 · 2023: $129 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $8,879.30 | 2019 | |
| Boston Scientific Corporation | $7,510.85 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $124.50 | 2019-2024 | Dupixent |
| Sun Pharmaceutical Industries INC. | $62.77 | 2023-2024 | Ilumya |
| Incyte Corporation | $43.02 | 2023 | Opzelura |
| Ucb, INC. | $30.48 | 2024 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.15 | 2023 | Spevigo |
| Celgene Corporation | $19.76 | 2019 | |
| Medtronic, INC. | $19.11 | 2023 | Closurefast |
| Almirall LLC | $15.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lukasz Maj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.